Drug Search Results

Luseogliflozin

Alternative Names: luseogliflozin, TS-071, TS071, TS 071
Latest Update: 2024-06-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: SGLT2 Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Japan | Malaysia | Philippines

Approved Indications: None

Known Adverse Events: None

Company: Taisho
Company Location: TOKYO M0 170-8655
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Luseogliflozin

Countries in Clinic: Japan

Active Clinical Trial Count: 1

Highest Development Phases

Phase 3: Type 2 Diabetes

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
jRCT2031200244	P3	Recruiting	Type 2 Diabetes	2025-03-31

Recent News Events

Date	Type	Title
06/01/2024	PubMed	Effect of Luseogliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, and Dipeptidyl-Peptidase 4 Inhibitors on the Quality-of-Life and Treatment Satisfaction of Patients With Type 2 Diabetes Mellitus: A Subanalysis of a Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT Study).
05/01/2024	PubMed	Effect of Luseogliflozin on Myocardial Flow Reserve in Patients with Type 2 Diabetes Mellitus (LUCENT-J Study).
04/12/2024	PubMed	The Early Pathogenesis of Diabetic Retinopathy and Its Attenuation by Sodium-Glucose Transporter 2 Inhibitors.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions